| Not Yet Recruiting | Evaluation of Skin Tests in Biotherapy Allergies NCT06971848 | University Hospital, Angers | N/A |
| Recruiting | A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors NCT07277413 | IDEAYA Biosciences | Phase 1 |
| Recruiting | The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma NCT06790082 | Aalborg University Hospital | Phase 2 |
| Active Not Recruiting | Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) NCT06155279 | Istituto Oncologico Veneto IRCCS | Phase 2 |
| Recruiting | A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369 | 7 Hills Pharma, LLC | Phase 1 / Phase 2 |
| Not Yet Recruiting | Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma NCT06416930 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Recruiting | A Study of MT027 in Patients with Pleural Malignant Tumors NCT06726564 | Suzhou Maximum Bio-tech Co., Ltd. | Phase 1 |
| Recruiting | Evaluation of Response by FLT PET in Mesothelioma NCT06410625 | Ankara University | N/A |
| Recruiting | TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO NCT05628376 | University College, London | — |
| Recruiting | Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable NCT05930665 | Sun Yat-sen University | Phase 2 |
| Recruiting | TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study NCT05538806 | NovoCure Ltd. | — |
| Recruiting | INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE NCT07403630 | Azienda Ospedaliero-Universitaria di Parma | N/A |
| Terminated | NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours NCT05714553 | NuCana plc | Phase 1 / Phase 2 |
| Suspended | A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers NCT05337735 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma NCT04823741 | Hospices Civils de Lyon | — |
| Terminated | A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Canc NCT04914897 | Sanofi | Phase 2 |
| Recruiting | A Beta-only IL-2 ImmunoTherapY Study NCT05086692 | Medicenna Therapeutics, Inc. | Phase 1 / Phase 2 |
| Completed | DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma NCT04334759 | PrECOG, LLC. | Phase 3 |
| Unknown | Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention NCT05910112 | University of Oxford | — |
| Completed | Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S NCT04430842 | Quadriga Biosciences, Inc. | Phase 1 |
| Completed | eRAPID: Online Symptom Reporting in Lung Cancer NCT04324437 | University of Leeds | N/A |
| Unknown | A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia NCT05077111 | Mohamed Reda Ashour | Phase 4 |
| Completed | From Presentation to Diagnosis: Patterns of Pleural Effusion NCT07449624 | Mansoura University Hospital | — |
| Terminated | A Study of SGN-CD228A in Advanced Solid Tumors NCT04042480 | Seagen Inc. | Phase 1 |
| Completed | Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma NCT04040231 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Terminated | Mesothelioma Early Detection by VOCs NCT04106973 | Henry Ford Health System | — |
| Completed | Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma NCT02899195 | PrECOG, LLC. | Phase 2 |
| Completed | Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program NCT02585362 | Kantonsspital Winterthur KSW | N/A |
| Terminated | A Pilot Window-Of-Opportunity Study of the Anti-PD-1 Antibody Pembrolizumab in Patients With Resectable Malign NCT02707666 | University of Chicago | Phase 1 |
| Unknown | International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) NCT03210298 | Sabine Rhode | — |
| Unknown | A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1 NCT02588131 | Italian Network for Tumor Biotherapy Foundation | Phase 2 |
| Completed | TILs & Low-Dose IL-2 Therapy Following Cyclophosphamide and Fludarabine in Pleural Mesothelioma Patients NCT02414945 | University Health Network, Toronto | Phase 1 / Phase 2 |
| Completed | Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy NCT01160458 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Pemetrexed (ALIMTA) Plus Cisplatin Followed by Surgery and Radiation Therapy for Mesothelioma NCT00895648 | University Health Network, Toronto | Phase 2 |
| Terminated | Trimodal Lung-Sparing Treatment of Pleural Mesothelioma NCT00859495 | Columbia University | Phase 2 |
| Completed | Gene Therapy for Pleural Malignancies NCT00299962 | University of Pennsylvania | Phase 1 |
| Terminated | Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thios NCT00165503 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine NCT00165516 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mes NCT00165555 | Dana-Farber Cancer Institute | Phase 1 |